GPCRStructure Therapeutics Inc.

$49.42

Who owns GPCR

195 institutions reported holding GPCR for 2026Q1, together 31% of the company, fewer than the 197 a quarter earlier.

195

Institutions reporting a position · as of 2026Q1 · down from 197 the quarter before

Shares held by institutions
66.7M

Shares held by institutions · 31% of the company · long US equity positions only, as reported on Form 13F

Reported value
$3.22B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
15%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
13
New positions
39
Positions exited
40
Added to
70
Reduced
59
Top 10 holdersof the company
20%
Institutional ownership by quarter, 2023Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q119566.7M$3.22B
2025Q419765.8M$4.58B
2025Q315656.6M$1.58B
2025Q217254.7M$1.13B
2025Q115055.9M$981M
2024Q416260.6M$1.64B
2024Q315861.4M$2.69B
2024Q216559.3M$2.33B
2024Q111843.6M$1.86B
2023Q412042.6M$1.74B
2023Q38432.8M$1.64B
2023Q24817.6M$699M
2023Q13814.8M$346M
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC8.4M3.9%$405M
WELLINGTON MANAGEMENT GROUP LLP7.3M3.3%$350M
Avoro Capital Advisors LLC6.6M3.0%$316M
HENDERSON GROUP PLC5.4M2.5%$258M
Deep Track Capital, LP4.3M2.0%$206M
BVF INC/IL3.5M1.6%$167M
MORGAN STANLEY2.3M1.1%$111M
PRICE T ROWE ASSOCIATES INC /MD/2.0M0.92%$96M
PRINCIPAL FINANCIAL GROUP INC1.8M0.81%$85M
Driehaus Capital Management LLC1.6M0.73%$76M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…